Monoclonal Antibody-Based Products Market to Reach $68.4 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

Share Article

Monoclonal antibodies represent one of the successes of the biotechnology industry along with a broad range of therapeutics and diagnostics. By the year 2015, monoclonal antibody-based products market is projected to reach $68.4 billion, primarily driven by rapid advances in technology that enable antibodies to specifically target disease-causing cells.

Monoclonal Antibody-Based Products: A Global Strategic Business Report

Monoclonal Antibody (MAb)-based products market, accounting for a third of biotech drugs in development, is one of the fastest growing categories of the biopharmaceuticals industry. These products are of high significance for pharmaceutical industry, both in research as well as drug development activities. MAbs function as production repositories for developing drugs, and are used in the manufacture of highly specialized diagnostic products. Rapid technological advancements that enable antibodies to specifically target disease-causing cells are expected to boost prospects in the global therapeutic and diagnostic monoclonal antibodies market.

United States and Europe are predominant players in the global market for Monoclonal antibody based products accounting for more than 95% share of the market, as stated in a recent report published by Global Industry Analysts, Inc. Therapeutic MAbs market is expected to make rapid strides, driven by exceptional performance of major products, launch of novel products, and absence of any significant generic competition. Also, alliances between biotechnology and pharmaceutical companies are expected to be a major growth booster for the segment. Increased focus on research activities, and rising demand for safer drugs with minimal side effects is also expected to bolster therapeutic MAbs market.

In the United States, therapeutic monoclonal antibody-based products market is projected to register sales of US$20.3 billion by 2010, while cancer therapeutics sub-segment is expected to post double-digit growth rates. With wide-ranging capabilities being exhibited, monoclonal antibodies are proving effective for treatment of various ailments including cancer, cardiovascular, autoimmune, inflammation, and infectious diseases.

In Europe, Germany, France, and the United Kingdom represent the leading markets, while other regional markets continue to make rapid gains, in terms of technological advancements and drug development, market recognition and corporate developments. Diagnostic monoclonal antibody-based products market in Germany is projected to exceed US$673 million by 2012.

Monoclonal antibody-based products market is witnessing intense competition, with players jostling for the top position. Buoyed by several launches, humanized antibodies market is gaining momentum. Key players profiled in the report include Amgen, BD Biosciences, Biogen Idec Inc, Biotest AG, Dendreon Corporation, CMC ICOS Biologics Inc., Elan Corporations Plc, Eli Lilly and Company, Genentech Inc., Human Genome Sciences Inc., Immunomedics Inc., Centocor, Medarex Inc., MedImmune Inc., PDL BioPharma, Schering-Plough Corporation, Strategic Diagnostics Inc, UCB Group, and Wyeth Pharmaceuticals.

The report titled "Monoclonal Antibody-Based Products: A Global Strategic Business Report" published by Global Industry Analysts, Inc., covers major market dynamics, trends, issues, and competition pertaining to the market. The report enumerates recent research and development activity, product introductions/developments, and strategic corporate activity of major market participants across various product categories. The market is analyzed across two major segments, namely Therapeutics (Cancer and Others), and Diagnostics. Analysis is presented for established and emerging markets including United States, Japan, France, Germany, United Kingdom, and Italy.

For more details of this research report, please visit

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Web Site


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website